Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Ittmann

Showing results (61-70 of 125) with videos related to

Pageof 13
Sort By:
Cancer Research|December 21, 2010
Activation of NF-{kappa}B by TMPRSS2/ERG Fusion Isoforms through Toll-Like Receptor-4Jianghua Wang, Yi Cai, Long-Jiang Shao, et al.
Cell Biology International|September 3, 2019
ING5 inhibits cancer aggressiveness by inhibiting Akt and activating p53 in prostate cancerNeslisah Barlak, Ozel Capik, Fatma Sanli, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2005
Mutation of the androgen receptor causes oncogenic transformation of the prostateGuangzhou Han, Grant Buchanan, Michael Ittmann, et al.
Cancers|December 24, 2021
Expression of Endogenous Retroviral RNA in Prostate Tumors has Prognostic Value and Shows Differences among Americans of African Versus European/Middle Eastern AncestryVinay Kumar, Michael McClelland, James Nguyen, et al.
Cancer Research|October 3, 2003
Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancerNathaniel Polnaszek, Bernard Kwabi-Addo, Leif E Peterson, et al.
Oncotarget|December 24, 2016
Combination treatment of prostate cancer with FGF receptor and AKT kinase inhibitorsShu Feng, Longjiang Shao, Patricia Castro, et al.
Plos One|June 27, 2014
miR-1 and miR-133b are differentially expressed in patients with recurrent prostate cancerOmer Faruk Karatas, Esra Guzel, Ilknur Suer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2012
Highly specific targeting of the TMPRSS2/ERG fusion gene using liposomal nanovectorsLongjiang Shao, Ibrahim Tekedereli, Jianghua Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2013
Semaphorin 4F as a critical regulator of neuroepithelial interactions and a biomarker of aggressive prostate cancerYi Ding, Dandan He, Diego Florentin, et al.
Cancer Research|June 15, 2017
RGS12 Is a Novel Tumor-Suppressor Gene in African American Prostate Cancer That Represses AKT and MNX1 ExpressionYongquan Wang, Jianghua Wang, Li Zhang, et al.
Pageof 13

Showing results (61-70 of 125) with videos related to

Sort By:
Pageof 13
Cancer Research|December 21, 2010
Activation of NF-{kappa}B by TMPRSS2/ERG Fusion Isoforms through Toll-Like Receptor-4Jianghua Wang, Yi Cai, Long-Jiang Shao, et al.
Cell Biology International|September 3, 2019
ING5 inhibits cancer aggressiveness by inhibiting Akt and activating p53 in prostate cancerNeslisah Barlak, Ozel Capik, Fatma Sanli, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2005
Mutation of the androgen receptor causes oncogenic transformation of the prostateGuangzhou Han, Grant Buchanan, Michael Ittmann, et al.
Cancers|December 24, 2021
Expression of Endogenous Retroviral RNA in Prostate Tumors has Prognostic Value and Shows Differences among Americans of African Versus European/Middle Eastern AncestryVinay Kumar, Michael McClelland, James Nguyen, et al.
Cancer Research|October 3, 2003
Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancerNathaniel Polnaszek, Bernard Kwabi-Addo, Leif E Peterson, et al.
Oncotarget|December 24, 2016
Combination treatment of prostate cancer with FGF receptor and AKT kinase inhibitorsShu Feng, Longjiang Shao, Patricia Castro, et al.
Plos One|June 27, 2014
miR-1 and miR-133b are differentially expressed in patients with recurrent prostate cancerOmer Faruk Karatas, Esra Guzel, Ilknur Suer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2012
Highly specific targeting of the TMPRSS2/ERG fusion gene using liposomal nanovectorsLongjiang Shao, Ibrahim Tekedereli, Jianghua Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2013
Semaphorin 4F as a critical regulator of neuroepithelial interactions and a biomarker of aggressive prostate cancerYi Ding, Dandan He, Diego Florentin, et al.
Cancer Research|June 15, 2017
RGS12 Is a Novel Tumor-Suppressor Gene in African American Prostate Cancer That Represses AKT and MNX1 ExpressionYongquan Wang, Jianghua Wang, Li Zhang, et al.
Pageof 13